- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Absence of coronary calcification not equivalent to absence of atherosclerosis in young adults: JAMA
The diagnostic value is not clear of a 0 coronary artery calcium (CAC) score to rule out obstructive coronary artery disease (CAD) and near-term clinical events across different age groups. In the current issue of JAMA Cardiology, Mortensen et al have shown that a sizable proportion of obstructive CAD can occur among young patients without CAC while more than 90% patients (with symptomatic CAD) in the elderly age group had a score more than zero. Thus the decision to defer statin therapy in young subjects for primary prevention should not be based solely on CAC scores.
Based on the available evidence of the role of CAC in improving the estimation of CVD risk, multisociety practice guidelines from the United States, Europe, and others endorse the selective use of CAC in adults aged 40 to 75 years with borderline or intermediate estimated 10-year atherosclerotic CVD risk to guide the intensification of preventive strategies (eg, lipid-lowering therapy).
When CAC is absent, current American Heart Association/American College of Cardiology guidelines recommend that clinicians consider providing no statin to some patients who are not at an elevated risk on the basis of smoking status, family history, and diabetes.
To assess the diagnostic value of a CAC score of 0 for reducing the likelihood of obstructive CAD and to assess the implications of such a CAC score and obstructive CAD across different age groups, Mortensen et al obtained data from the Western Denmark Heart Registry with median follow-up time of 4.3 years.
The study included patients were aged 18 years or older who underwent computed tomography angiography (CTA) because of symptoms that were suggestive of CAD. Obstructive CAD was defined as 50% or more luminal stenosis. Risk-adjusted diagnostic likelihood ratios were used to assess the diagnostic value of a CAC score of 0 for reducing the likelihood of obstructive CAD beyond clinical variables.
The study provided following results:
1. Among 23 759 patients 54% had a CAC score of 0 and 21% had obstructive CAD.
2. Among those with evidence of obstructive CAD, 14% had a 0 CAC score.
3. When stratified by age, younger adults with obstructive disease were far less likely than older adults to have any CAC; 58% of patients aged 18 to 39 years with obstructive disease had 0 CAC score compared with only 5% of patients who were 70 years or older with obstructive disease.
4. Women with obstructive disease were also less likely to have any CAC, suggesting that CAC scoring may perform worse as a strategy to identify younger adults and women who may not benefit from statins.
5. Although the proportion of the overall cohort with a CAC score of 0 was low (14%), their overall burden of disease was high.
6. At a median follow-up of 4.3 years, nearly one-third of events occurred in those with a CAC score of 0.
"These findings are not surprising given what is known about the biological processes involved in atherosclerosis. The processes leading to CAC begin early in life and take decades to progress from early atherosclerotic lesions to calcified plaques. Thus, many adults, particularly earlier in life, who will subsequently develop clinically significant atherosclerosis may have noncalcified lesions but a CAC score of 0", write Khan et al in an accompanying editorial.
The analysis by Mortensen et al is an important addition to the literature, highlighting the potential limitations of CAC scoring to identify those who may benefit from statin therapy, particularly in younger adults. This study should be a reminder to physicians that the absence of CAC is not equivalent to the absence of atherosclerosis, particularly in younger adults and women. When CAC scoring is used in these populations, clinicians should remind patients that a CAC score of 0 is not a guarantee against CVD.
"The goal of primary prevention should be to prevent the atherosclerotic lesions that lead to CAC, not to wait for CAC to develop before initiating risk-lowering therapy", conclude Khan et al.
Source: JAMA Cardiology:
1. doi:10.1001/jamacardio.2021.4406
2. doi:10.1001/jamacardio.2021.4413
MBBS, MD , DM Cardiology
Dr Abhimanyu Uppal completed his M. B. B. S and M. D. in internal medicine from the SMS Medical College in Jaipur. He got selected for D. M. Cardiology course in the prestigious G. B. Pant Institute, New Delhi in 2017. After completing his D. M. Degree he continues to work as Post DM senior resident in G. B. pant hospital. He is actively involved in various research activities of the department and has assisted and performed a multitude of cardiac procedures under the guidance of esteemed faculty of this Institute. He can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751